Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA.

scientific article published on 2 July 2012

Imaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA. is …
instance of (P31):
MDMAQ69488
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/neuroimage/LettfussFSPA12
P356DOI10.1016/J.NEUROIMAGE.2012.06.051
P698PubMed publication ID22766162

P50authorVesna SossiQ67175776
P2093author name stringAndreas von Ameln-Mayerhofer
Bernd J Pichler
Kristina Fischer
Nadine Y Lettfuss
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectdyskinesiaQ629444
P304page(s)423-433
P577publication date2012-07-02
P1433published inNeuroImageQ1981225
P1476titleImaging DA release in a rat model of L-DOPA-induced dyskinesias: a longitudinal in vivo PET investigation of the antidyskinetic effect of MDMA.
P478volume63

Reverse relations

cites work (P2860)
Q64105363Botulinum Neurotoxin-A Injected Intrastriatally into Hemiparkinsonian Rats Improves the Initiation Time for Left and Right Forelimbs in Both Forehand and Backhand Directions
Q30833645Brain morphometry and the neurobiology of levodopa-induced dyskinesias: current knowledge and future potential for translational pre-clinical neuroimaging studies.
Q48146478Intrastriatal administration of botulinum neurotoxin A normalizes striatal D2 R binding and reduces striatal D1 R binding in male hemiparkinsonian rats.
Q42465875MDMA modulates spontaneous firing of subthalamic nucleus neurons in vitro
Q35165280Monoamine reuptake inhibitors in Parkinson's disease
Q51482161Neurochemical binding profiles of novel indole and benzofuran MDMA analogues.

Search more.